• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Pacira BioSciences, Inc. - Common Stock (NQ:PCRX)

    25.17 -0.41 (-1.60%)
    Streaming Delayed Price Updated: 1:55 PM EDT, Aug 7, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 320,799
    Open 25.67
    Bid (Size) 25.09 (100)
    Ask (Size) 25.21 (200)
    Prev. Close 25.58
    Today's Range 24.93 - 25.68
    52wk Range 18.80 - 27.66
    Shares Outstanding 44,454,792
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Pacira BioSciences Announces Publication of Positive Two-Year Phase 1 Data For PCRX-201 in Annals of the Rheumatic Diseases
    From Pacira BioSciences
    Via GlobeNewswire
    News headline image
    Pacira BioSciences Q2 Earnings Call Highlights ↗
    Pacira BioSciences (NASDAQ:PCRX) reported second-quarter 2026 revenue growth, led by higher sales of its EXPAREL, ZILRETTA and iovera° products, while highlighting expanded payer coverage, pipeline... 
    Via MarketBeat
    Topics Earnings

    Performance

    YTD
    +2.9%
    +2.9%
    1 Month
    -2.5%
    -2.5%
    3 Month
    +6.5%
    +6.5%
    6 Month
    +23.6%
    +23.6%
    1 Year
    +12.4%
    +12.4%

    More News

    Read More
    Pacira Biosciences (NASDAQ:PCRX) Beats Q2 EPS Estimates, Misses on Revenue and Cuts Outlook ↗
    Via Chartmill
    News headline image
    Pacira BioSciences Reports Second Quarter 2026 Financial Results
    From Pacira BioSciences
    Via GlobeNewswire
    News headline image
    Pacira BioSciences Announces New National Survey Revealing the Hidden Toll of Pain on America’s Workforce
    From Pacira BioSciences
    Via GlobeNewswire
    Pacira Biosciences Inc (NASDAQ:PCRX) Emerges as a Deep Value Opportunity with Strong Financial Health ↗
    Via Chartmill
    PACIRA BIOSCIENCES INC (NASDAQ:PCRX): A Value Stock Candidate with Margin of Safety ↗
    Via Chartmill
    News headline image
    Pacira BioSciences Advances PCRX-201 Development Program with Successful Transition to Scalable Commercial Manufacturing Process
    From Pacira BioSciences
    Via GlobeNewswire
    News headline image
    Pacira to Report Second Quarter 2026 Financial Results on Tuesday August 4, 2026
    From Pacira BioSciences
    Via GlobeNewswire
    News headline image
    Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Pacira BioSciences
    Via GlobeNewswire
    News headline image
    Pacira BioSciences Announces UnitedHealthcare Now Provides Separate Reimbursement for EXPAREL®
    From Pacira BioSciences
    Via GlobeNewswire
    News headline image
    Pacira BioSciences Announces Agreement to Divest its iovera° Business to Zimmer Biomet
    From Pacira BioSciences
    Via GlobeNewswire
    News headline image
    Leading Independent Proxy Advisory Firm Glass Lewis Recommends Stockholders Vote “FOR” All of Pacira’s Director Nominees
    From Pacira BioSciences
    Via GlobeNewswire
    News headline image
    Pacira BioSciences Mails Letter to Stockholders Reiterating Confidence in the Company’s Strategic Direction and Highly Qualified Nominees
    From Pacira BioSciences
    Via GlobeNewswire
    News headline image
    After Fifty Years of Implants, a Newly Public Biotech Is Trying to Rebuild the Breast Instead
    From Biotech Insider
    Via GlobeNewswire
    News headline image
    Pacira BioSciences Reports Real-World Study Showing EXPAREL® Use Was Associated with Reduced Opioid Use and Healthcare Costs in Patients Undergoing Total Shoulder Arthroplasty
    From Pacira BioSciences
    Via GlobeNewswire
    News headline image
    Pacira BioSciences Sets the Record Straight Regarding DOMA’s Misleading Statements About Pacira’s Intellectual Property Strategy
    From Pacira BioSciences
    Via GlobeNewswire
    News headline image
    A Reno Biotech Just Rang the Nasdaq Bell — Here’s Why the Whole Regenerative-Medicine Tape Is Worth Watching
    From World Street Intelligence
    Via GlobeNewswire
    News headline image
    Pacira BioSciences Files Investor Presentation Highlighting Successful Execution of its Long-Term Strategy to Drive Value for All Stockholders
    From Pacira BioSciences
    Via GlobeNewswire
    News headline image
    Pacira BioSciences to Participate in Fireside Chats at Three Upcoming Healthcare Conferences
    From Pacira BioSciences
    Via GlobeNewswire
    News headline image
    Pacira BioSciences Sends Letter to Stockholders Reiterating Superior Qualifications of its Board Nominees
    From Pacira BioSciences
    Via GlobeNewswire
    News headline image
    Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Pacira BioSciences
    Via GlobeNewswire
    News headline image
    Pacira BioSciences Mails Letter to Stockholders
    From Pacira BioSciences
    Via GlobeNewswire
    News headline image
    Pacira BioSciences' CFO Sold 12,941 Shares for $326,000 Before Its Q1 Earnings Release ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Pacira (PCRX) Q1 2026 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings

    Frequently Asked Questions

    Is Pacira BioSciences, Inc. - Common Stock publicly traded?
    Yes, Pacira BioSciences, Inc. - Common Stock is publicly traded.
    What exchange does Pacira BioSciences, Inc. - Common Stock trade on?
    Pacira BioSciences, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Pacira BioSciences, Inc. - Common Stock?
    The ticker symbol for Pacira BioSciences, Inc. - Common Stock is PCRX on the Nasdaq Stock Market
    What is the current price of Pacira BioSciences, Inc. - Common Stock?
    The current price of Pacira BioSciences, Inc. - Common Stock is 25.17
    When was Pacira BioSciences, Inc. - Common Stock last traded?
    The last trade of Pacira BioSciences, Inc. - Common Stock was at 08/07/26 01:55 PM ET
    What is the market capitalization of Pacira BioSciences, Inc. - Common Stock?
    The market capitalization of Pacira BioSciences, Inc. - Common Stock is 1.12B
    How many shares of Pacira BioSciences, Inc. - Common Stock are outstanding?
    Pacira BioSciences, Inc. - Common Stock has 1B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.